Crescita Therapeutics Inc. (CTX.TO) TSX
0.79
+0.04(+5.33%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.05M |
| Enterprise Value | 805,952 |
| P/E Ratio | -45.95 |
| PEG Ratio | -1.9 |
| Price/Sales Ratio | 0.63 |
| Price/Book Ratio | 1.02 |
| Enterprise/Revenue | 0.37 |
| Enterprise/EBITDA | 5.58 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.01 |
| Operating Margin | -0.05 |
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.02 |
Income Statement
| Revenue | 21.12M |
| Revenue/Share | 1.25 |
| Gross Profit | 10.37M |
| EBITDA | 479,000 |
| Net Income | -92,000 |
| Diluted EPS | -0 |
Balance Sheet
| Total Cash | 8.71M |
| Total Cash/Share | 0.47 |
| Total Debt | 2.5M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 2.8 |
| Book Value Per Share | 0.77 |
Price History
| 52-Week Change | 51.92 |
| 52-Week High | 0.79 |
| 52-Week Low | 0.4 |
| Moving Average 50 Days | 0.75 |
| Moving Average 200 Days | 0.54 |
Statistics
| Average Volume | 33,917 |
| Shares Outstanding | 18.61M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 209:200 |
| Last Split Date | February 06, 2018 |
